Chelating Agents for the Treatment of Systemic Iron Overload

E-ISSN： 1875-533x|19|17|2816-2827

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.17, 2012-06, pp. : 2816-2827

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Iron Chelating Strategies in Systemic Metal Overload, Neurodegeneration and Cancer

Current Medicinal Chemistry, Vol. 21, Iss. 33, 2014-11 ,pp. : 3741-3767

Bentham Science Publishers

Access to resources Recommend Favorite

New chelation therapies and emerging chelating drugs for the treatment of iron overload

By Kontoghiorghes George J

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 1-5

Informa Healthcare

Access to resources Recommend Favorite

Myelodysplastic Syndromes: Iron Overload Consequences and Current Chelating Therapies

By Greenberg Peter L.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 1, 2006-01 ,pp. : 91-96

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New Pharmacological Concepts for the Treatment of Iron Overload Disorders

Current Medicinal Chemistry, Vol. 16, Iss. 5, 2009-02 ,pp. : 576-590

Bentham Science Publishers

Access to resources Recommend Favorite

Development of agents for the treatment of systemic sclerosis

By Herrick Ariane L

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1255-1264

Informa Healthcare

Access to resources Recommend Favorite